| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2349b3d70a72921a69f7aced092af1a7 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y02A50-30 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-475 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P37-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K36-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-475
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-435
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-785
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-70
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-35
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K36-00 |
| filingDate |
1989-11-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3b71e9122d8213751ffd74ef4eb1c009 |
| publicationDate |
1990-06-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
EP-0373986-A1 |
| titleOfInvention |
Anti-virus composition and its uses |
| abstract |
A pharmaceutical composition containing: (1) Flavopereirine and / or dihydroflavopereirine; (2) one or more compounds selected from the group consisting of naringin, naringenin and / or their pharmaceutically acceptable esters or salts; (3) initiator RNA or R.L.B. (RNA fragments); (4) Bioparyl. Flavopereirine is an alkaloid in the class of Beta-carboline. R.L.B. are particular fragments of RNA which act as initiators for the replication of the DNA of leukocytes. Bioparyl is obtained from yellow leaves of the Gingko Biloba tree by a special process of extraction, hydrolysis and separation. These combination products are useful for treating patients suffering from viral diseases, particularly AIDS. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5519028-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9421269-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11083714-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6555523-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9402146-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/DE-4308443-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/DE-4208868-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-107501224-B
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-107501224-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-0103681-A3
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9214478-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-0103681-A2 |
| priorityDate |
1988-12-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |